Focal therapy (FT) for prostate cancer, also referred to as partial gland ablation, aims to
reduce prostate cancer treatment morbidity while attaining sufficient oncological control …

Purpose: Our aim was to assess oncologic, safety, and quality of life–related outcomes of
focal therapy with irreversible electroporation in men with localized prostate cancer …

Irreversible electroporation (IRE) is a new non-thermal ablation modality that uses short
pulses of DC electric current to create irreversible pores in the cell membrane thus causing …

Focal therapy for localised prostate cancer has gained attention over the last decade as
patients and clinicians attempt to find the 'Holy Grail'of a cure for localised prostate cancer …

Background Current surgical and ablative treatment options for prostate cancer (PCa) may
result in a high incidence of (temporary) incontinence, erectile dysfunction and/or bowel …

Background: Current data on the use of irreversible electroporation (IRE) in the treatment of
prostate cancer (PCa) is limited. We aim to evaluate the safety, short-term functional and …

RESULTS: Fifteen consecutive men received focal IRE treatment (08/2011-09/2012) for low,
intermediate and highrisk disease (D'Amico classification) in 7%, 80% and 13 …

Irreversible electroporation (IRE) is a new nonthermal ablation modality that uses short
pulses of DC electric current to create irreversible pores in the cell membrane thus causing …

Introduction Irreversible electroporation (IRE) technology for prostate cancer (PC) generates
consecutive electrical pulses between pairs of electrodes which move through tumorous …

A small clinical study from groups in London and Sydney has shown that irreversible
electroporation (IRE) is an effective treatment for prostate tumours, with an excellent safety …